speb/financial-data huggingface dataset:
PHI balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 9928000000.00
PHI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 17636000000.00
PHI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 204000000.00
PHI balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1745000000.00
PHI balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 81219000000.00
PHI income_statement (annual, 2022-12-31) — Normalized EBITDA: 105972000000.00
PHI income_statement (annual, 2022-12-31) — Normalized Income: -3896393244.01
PHI cash_flow (annual, 2022-12-31) — Operating Cash Flow: 76200000000.00
PHI cash_flow (annual, 2022-12-31) — Operating Gains Losses: -17972000000.00
PHI income_statement (annual, 2022-12-31) — Operating Income: 979000000.00
PHI income_statement (annual, 2022-12-31) — Operating Revenue: 204362000000.00
PHI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (annual, 2022-12-31) — Other Current Assets: 15364000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 32292000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 5085000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -35482000000.00
PHI income_statement (annual, 2022-12-31) — Other Gand A: 11860000000.00
PHI income_statement (annual, 2022-12-31) — Other Income Expense: 24159000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1608000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Inventories: 881000000.00
PHI cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1175000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 81219000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 56000000.00
PHI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 8917000000.00
PHI income_statement (annual, 2022-12-31) — Other Operating Expenses: 28923000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Payable: 18395000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Properties: 83242000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Receivables: 1571000000.00
PHI balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 589000000.00
PHI income_statement (annual, 2022-12-31) — Other Special Charges: -295000000.00
PHI income_statement (annual, 2022-12-31) — Other Taxes: 4044000000.00
PHI balance_sheet (annual, 2022-12-31) — Payables: 117435000000.00
PHI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 183034000000.00
PHI cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 3021000000.00
PHI balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6615000000.00
PHI balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 450000000.00
PHI balance_sheet (annual, 2022-12-31) — Preferred Stock: 510000000.00
PHI income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 59000000.00
PHI balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 510000000.00
PHI cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 7839000000.00
PHI balance_sheet (annual, 2022-12-31) — Prepaid Assets: 14696000000.00
PHI income_statement (annual, 2022-12-31) — Pretax Income: 14032000000.00
PHI balance_sheet (annual, 2022-12-31) — Properties: 0.00
PHI cash_flow (annual, 2022-12-31) — Purchase Of Business: -3514000000.00
PHI cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
PHI cash_flow (annual, 2022-12-31) — Purchase Of Investment: -6550000000.00
PHI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -93803000000.00
PHI balance_sheet (annual, 2022-12-31) — Raw Materials: 577000000.00
PHI balance_sheet (annual, 2022-12-31) — Receivables: 27826000000.00
PHI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 20193000000.00
PHI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 98942000000.00
PHI income_statement (annual, 2022-12-31) — Rent And Landing Fees: 2031000000.00
PHI income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 2031000000.00
PHI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -36684000000.00
PHI balance_sheet (annual, 2022-12-31) — Retained Earnings: 18799000000.00
PHI income_statement (annual, 2022-12-31) — Salaries And Wages: 29256000000.00
PHI cash_flow (annual, 2022-12-31) — Sale Of Business: 2458000000.00
PHI cash_flow (annual, 2022-12-31) — Sale Of Investment: 8882000000.00
PHI cash_flow (annual, 2022-12-31) — Sale Of PPE: 60833000000.00
PHI income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 6558000000.00
PHI income_statement (annual, 2022-12-31) — Selling General And Administration: 51281000000.00
PHI balance_sheet (annual, 2022-12-31) — Share Issued: 219055775.00
PHI cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 16000000000.00
PHI cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -6000000000.00
PHI income_statement (annual, 2022-12-31) — Special Income Charges: 20911000000.00
PHI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 108727000000.00
PHI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 43668000000.00
PHI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 3564606755.99
PHI income_statement (annual, 2022-12-31) — Tax Provision: 2697000000.00
PHI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
PHI cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -4188000000.00
PHI balance_sheet (annual, 2022-12-31) — Total Assets: 624162000000.00
PHI balance_sheet (annual, 2022-12-31) — Total Capitalization: 326015000000.00
PHI balance_sheet (annual, 2022-12-31) — Total Debt: 292015000000.00
PHI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 113961000000.00
PHI income_statement (annual, 2022-12-31) — Total Expenses: 203383000000.00
PHI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 510201000000.00
PHI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 542833000000.00
PHI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 263199000000.00
PHI income_statement (annual, 2022-12-31) — Total Other Finance Cost: 215000000.00
PHI balance_sheet (annual, 2022-12-31) — Total Tax Payable: 14479000000.00
PHI income_statement (annual, 2022-12-31) — Total Unusual Items: 18546000000.00
PHI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 18546000000.00
PHI balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 3000000.00
PHI balance_sheet (annual, 2022-12-31) — Treasury Stock: 6505000000.00
PHI balance_sheet (annual, 2022-12-31) — Working Capital: -165673000000.00
PHI income_statement (annual, 2022-12-31) — Write Off: 5762000000.00
PHI income_statement (annual, 2023-12-31) — +Operating Expense: 140317000000.00
PHI income_statement (annual, 2023-12-31) — +Total Revenue: 210953000000.00
PHI balance_sheet (annual, 2023-12-31) — Accounts Payable: 81014000000.00
PHI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 26086000000.00
PHI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -16611000000.00
PHI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 130312000000.00
PHI balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -17215000000.00
PHI income_statement (annual, 2023-12-31) — Amortization: 221000000.00
PHI cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 221000000.00
PHI cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 221000000.00
PHI income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 221000000.00
PHI cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 4502000000.00
PHI balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 9007000000.00
PHI balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 3876000000.00
PHI income_statement (annual, 2023-12-31) — Basic Average Shares: 216532422.00
PHI income_statement (annual, 2023-12-31) — Basic EPS: 122.91
PHI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 25211000000.00
PHI balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 1144000000.00
PHI cash_flow (annual, 2023-12-31) — Capital Expenditure: -78435000000.00
PHI cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -2169000000.00
PHI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 47546000000.00
PHI balance_sheet (annual, 2023-12-31) — Capital Stock: 1603000000.00
PHI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 16177000000.00
PHI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 17088000000.00
PHI cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -23328000000.00
PHI balance_sheet (annual, 2023-12-31) — Cash Equivalents: 6184000000.00
PHI balance_sheet (annual, 2023-12-31) — Cash Financial: 9993000000.00
PHI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -39418000000.00
PHI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -55118000000.00
PHI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 85765000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Account Payable: -21285000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -4414000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Inventory: 597000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 156000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -57000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -5249000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Payable: -21285000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -25699000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 10264000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Receivables: 1053000000.00
PHI cash_flow (annual, 2023-12-31) — Change In Working Capital: -18935000000.00
PHI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 952000000.00
PHI cash_flow (annual, 2023-12-31) — Changes In Cash: -8771000000.00
PHI balance_sheet (annual, 2023-12-31) — Common Stock: 1093000000.00
PHI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 104708000000.00
PHI balance_sheet (annual, 2023-12-31) — Construction In Progress: 67840000000.00
PHI income_statement (annual, 2023-12-31) — Cost Of Revenue: 25510000000.00
PHI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 88750000000.00
PHI balance_sheet (annual, 2023-12-31) — Current Assets: 70123000000.00
PHI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 5921000000.00
PHI balance_sheet (annual, 2023-12-31) — Current Debt: 11646000000.00
PHI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 17567000000.00
PHI balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 10689000000.00
PHI balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 10689000000.00
PHI balance_sheet (annual, 2023-12-31) — Current Liabilities: 196673000000.00
PHI cash_flow (annual, 2023-12-31) — Depreciation: 58683000000.00
PHI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 58683000000.00
PHI income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 58662000000.00
PHI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 58683000000.00
PHI income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 58662000000.00
PHI income_statement (annual, 2023-12-31) — Depreciation Income Statement: 58441000000.00
PHI balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 12000000.00
PHI income_statement (annual, 2023-12-31) — Diluted Average Shares: 216532422.00
PHI income_statement (annual, 2023-12-31) — Diluted EPS: 122.91
PHI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 25230000000.00
PHI balance_sheet (annual, 2023-12-31) — Dividends Payable: 1912000000.00
PHI balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 170000000.00
PHI income_statement (annual, 2023-12-31) — EBIT: 48375000000.00
PHI income_statement (annual, 2023-12-31) — EBITDA: 107058000000.00
PHI income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -2806000000.00
PHI cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 2806000000.00
PHI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -263000000.00
PHI balance_sheet (annual, 2023-12-31) — Employee Benefits: 5661000000.00
PHI cash_flow (annual, 2023-12-31) — End Cash Position: 16177000000.00
PHI balance_sheet (annual, 2023-12-31) — Financial Assets: 96000000.00
PHI balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 578000000.00
PHI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -39418000000.00
PHI balance_sheet (annual, 2023-12-31) — Finished Goods: 1747000000.00
PHI cash_flow (annual, 2023-12-31) — Free Cash Flow: 7330000000.00
PHI cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 743000000.00
PHI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
PHI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -8245000000.00
PHI income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
PHI income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 8245000000.00
PHI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 665000000.00
PHI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -39165000000.00
PHI income_statement (annual, 2023-12-31) — General And Administrative Expense: 38217000000.00
PHI balance_sheet (annual, 2023-12-31) — Goodwill: 62941000000.00
PHI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 64335000000.00
PHI balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 43301000000.00
PHI balance_sheet (annual, 2023-12-31) — Gross PPE: 336431000000.00
PHI income_statement (annual, 2023-12-31) — Gross Profit: 185443000000.00
PHI balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 0.00
PHI income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
PHI balance_sheet (annual, 2023-12-31) — Income Tax Payable: 4630000000.00
PHI income_statement (annual, 2023-12-31) — Insurance And Claims: 1344000000.00
PHI income_statement (annual, 2023-12-31) — Interest Expense: 13665000000.00
PHI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 13665000000.00
PHI income_statement (annual, 2023-12-31) — Interest Income: 1016000000.00
PHI income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1016000000.00
PHI cash_flow (annual, 2023-12-31) — Interest Paid Cff: -9715000000.00
PHI balance_sheet (annual, 2023-12-31) — Interest Payable: 2157000000.00
PHI cash_flow (annual, 2023-12-31) — Interest Received Cfi: 973000000.00
PHI balance_sheet (annual, 2023-12-31) — Inventory: 3340000000.00
PHI balance_sheet (annual, 2023-12-31) — Invested Capital: 359506000000.00
PHI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -55118000000.00
PHI balance_sheet (annual, 2023-12-31) — Investment Properties: 1315000000.00
PHI balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 4454000000.00
PHI balance_sheet (annual, 2023-12-31) — Investments And Advances: 54762000000.00
PHI balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 16618000000.00
PHI balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 33690000000.00
PHI cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
PHI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 38000000000.00
PHI balance_sheet (annual, 2023-12-31) — Land And Improvements: 38514000000.00
PHI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 41625000000.00
PHI balance_sheet (annual, 2023-12-31) — Long Term Debt: 243152000000.00
PHI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 284777000000.00
PHI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 38000000000.00
PHI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -33318000000.00
PHI balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 50308000000.00
PHI balance_sheet (annual, 2023-12-31) — Long Term Provisions: 1164000000.00
PHI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 715186000000.00
PHI balance_sheet (annual, 2023-12-31) — Minority Interest: 5168000000.00
PHI income_statement (annual, 2023-12-31) — Minority Interests: -210000000.00
PHI cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -1636000000.00
PHI balance_sheet (annual, 2023-12-31) — Net Debt: 238621000000.00
PHI cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -1153000000.00
PHI income_statement (annual, 2023-12-31) — Net Income: 25289000000.00
PHI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 25230000000.00
PHI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 25540000000.00
PHI income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -41000000.00
PHI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 25289000000.00
PHI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 25330000000.00
PHI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 34669000000.00
PHI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 25499000000.00
PHI cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
PHI income_statement (annual, 2023-12-31) — Net Interest Income: -12739000000.00
PHI cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 9000000.00
PHI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -5318000000.00
PHI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 4682000000.00
PHI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -12739000000.00
PHI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1057000000.00
PHI balance_sheet (annual, 2023-12-31) — Net PPE: 319820000000.00
PHI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -52295000000.00
PHI cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
PHI cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -10000000000.00
PHI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 40883000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 531000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 198000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 18172000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2403000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 2238000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 18172000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 165000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 5661000000.00
PHI balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 80365000000.00
PHI income_statement (annual, 2023-12-31) — Normalized EBITDA: 102580000000.00
PHI income_statement (annual, 2023-12-31) — Normalized Income: 22035038317.49
PHI cash_flow (annual, 2023-12-31) — Operating Cash Flow: 85765000000.00
PHI cash_flow (annual, 2023-12-31) — Operating Gains Losses: -3584000000.00
PHI income_statement (annual, 2023-12-31) — Operating Income: 45126000000.00
PHI income_statement (annual, 2023-12-31) — Operating Revenue: 210953000000.00
PHI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (annual, 2023-12-31) — Other Current Assets: 13215000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 11646000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 2800000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -39165000000.00
PHI income_statement (annual, 2023-12-31) — Other Gand A: 10857000000.00
PHI income_statement (annual, 2023-12-31) — Other Income Expense: 2323000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1394000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Inventories: 642000000.00
PHI cash_flow (annual, 2023-12-31) — Other Non Cash Items: 12488000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 80365000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 9607000000.00
PHI income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 651000000.00
PHI income_statement (annual, 2023-12-31) — Other Operating Expenses: 30186000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Properties: 296773000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Receivables: 1387000000.00
PHI balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 911000000.00
PHI income_statement (annual, 2023-12-31) — Other Taxes: 5215000000.00
PHI balance_sheet (annual, 2023-12-31) — Payables: 87556000000.00
PHI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 176306000000.00
PHI cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 2265000000.00
PHI balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5510000000.00
PHI balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 450000000.00
PHI balance_sheet (annual, 2023-12-31) — Preferred Stock: 510000000.00
PHI income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 59000000.00
PHI balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 510000000.00
PHI cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
PHI income_statement (annual, 2023-12-31) — Pretax Income: 34710000000.00
PHI balance_sheet (annual, 2023-12-31) — Properties: 0.00
PHI cash_flow (annual, 2023-12-31) — Purchase Of Business: -1636000000.00
PHI cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
PHI cash_flow (annual, 2023-12-31) — Purchase Of Investment: -449000000.00
PHI cash_flow (annual, 2023-12-31) — Purchase Of PPE: -76266000000.00
PHI balance_sheet (annual, 2023-12-31) — Raw Materials: 951000000.00
PHI balance_sheet (annual, 2023-12-31) — Receivables: 27473000000.00
PHI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 25489000000.00
PHI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 58683000000.00
PHI income_statement (annual, 2023-12-31) — Rent And Landing Fees: 1372000000.00
PHI income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 1372000000.00
PHI cash_flow (annual, 2023-12-31) — Repayment Of Debt: -43318000000.00
PHI balance_sheet (annual, 2023-12-31) — Retained Earnings: 18973000000.00
PHI income_statement (annual, 2023-12-31) — Salaries And Wages: 24644000000.00
PHI cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
PHI cash_flow (annual, 2023-12-31) — Sale Of Investment: 458000000.00
PHI cash_flow (annual, 2023-12-31) — Sale Of PPE: 23971000000.00
PHI income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 8037000000.00
PHI income_statement (annual, 2023-12-31) — Selling General And Administration: 46254000000.00
PHI balance_sheet (annual, 2023-12-31) — Share Issued: 219055775.00
PHI cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
PHI cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -10000000000.00
PHI income_statement (annual, 2023-12-31) — Special Income Charges: 3813000000.00
PHI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 105218000000.00
PHI balance_sheet (annual, 2023-12-31) — Tangible Book Value: 40373000000.00
PHI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 1183038317.49
PHI income_statement (annual, 2023-12-31) — Tax Provision: 9170000000.00
PHI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
PHI cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -2058000000.00
PHI balance_sheet (annual, 2023-12-31) — Total Assets: 609519000000.00
PHI balance_sheet (annual, 2023-12-31) — Total Capitalization: 348370000000.00
PHI balance_sheet (annual, 2023-12-31) — Total Debt: 302344000000.00
PHI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 110386000000.00
PHI income_statement (annual, 2023-12-31) — Total Expenses: 165827000000.00
PHI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 499133000000.00
PHI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 539396000000.00
PHI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 302460000000.00
PHI income_statement (annual, 2023-12-31) — Total Other Finance Cost: 90000000.00
PHI balance_sheet (annual, 2023-12-31) — Total Tax Payable: 4630000000.00
PHI income_statement (annual, 2023-12-31) — Total Unusual Items: 4478000000.00
PHI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 4478000000.00
PHI balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 3000000.00
PHI balance_sheet (annual, 2023-12-31) — Treasury Stock: 6505000000.00
PHI balance_sheet (annual, 2023-12-31) — Working Capital: -126550000000.00
PHI income_statement (annual, 2023-12-31) — Write Off: 4432000000.00
PHI cash_flow (quarterly, 2024-09-30) — Amortization Cash Flow: 59000000.00
PHI cash_flow (quarterly, 2024-09-30) — Amortization Of Intangibles: 59000000.00
PHI income_statement (quarterly, 2024-09-30) — Basic Average Shares: 216427611.00
PHI income_statement (quarterly, 2024-09-30) — Basic EPS: 44.62
PHI cash_flow (quarterly, 2024-09-30) — Depreciation: 12881000000.00
PHI income_statement (quarterly, 2024-09-30) — Depreciation Income Statement: 12881000000.00
PHI balance_sheet (quarterly, 2024-09-30) — Derivative Product Liabilities: 0.00
PHI income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 216427611.00
PHI income_statement (quarterly, 2024-09-30) — Diluted EPS: 44.62
PHI balance_sheet (quarterly, 2024-09-30) — Finished Goods: 1147000000.00
PHI income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
PHI balance_sheet (quarterly, 2024-09-30) — Raw Materials: 511000000.00
PHI income_statement (annual, 2024-12-31) — +Operating Expense: 134296000000.00
PHI income_statement (annual, 2024-12-31) — +Total Revenue: 216833000000.00
PHI balance_sheet (annual, 2024-12-31) — Accounts Payable: 61103000000.00
PHI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 31612000000.00
PHI balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -576856000000.00
PHI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 130312000000.00
PHI balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -17196000000.00
PHI income_statement (annual, 2024-12-31) — Amortization: 7689000000.00
PHI income_statement (quarterly, 2024-12-31) — Amortization: 69000000.00
PHI cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 240000000.00
PHI cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 69000000.00
PHI cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 240000000.00
PHI cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 69000000.00
PHI income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 7689000000.00
PHI income_statement (quarterly, 2024-12-31) — Amortization Of Intangibles Income Statement: 69000000.00
PHI cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 4319000000.00
PHI balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 6501000000.00
PHI balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 3496000000.00
PHI income_statement (annual, 2024-12-31) — Basic Average Shares: 216447809.00
PHI income_statement (annual, 2024-12-31) — Basic EPS: 149.26
PHI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 16177000000.00
PHI balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 29185000000.00
PHI cash_flow (annual, 2024-12-31) — Capital Expenditure: -68286000000.00
PHI cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -2589000000.00
PHI balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 54038000000.00
PHI balance_sheet (annual, 2024-12-31) — Capital Stock: 1603000000.00
PHI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 10011000000.00
PHI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 11003000000.00
PHI cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -20750000000.00
PHI balance_sheet (annual, 2024-12-31) — Cash Equivalents: 1464000000.00
PHI balance_sheet (annual, 2024-12-31) — Cash Financial: 8547000000.00
PHI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -22331000000.00
PHI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -65704000000.00
PHI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 81731000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Account Payable: -27765000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -8716000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Inventory: 31000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -1824000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -20000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -3549000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Payable: -27765000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -36481000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 21036000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Receivables: -9276000000.00
PHI cash_flow (annual, 2024-12-31) — Change In Working Capital: -30083000000.00
PHI cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -9137000000.00
PHI cash_flow (annual, 2024-12-31) — Changes In Cash: -6304000000.00
PHI balance_sheet (annual, 2024-12-31) — Common Stock: 1093000000.00
PHI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 114909000000.00
PHI balance_sheet (annual, 2024-12-31) — Construction In Progress: 68218000000.00
PHI income_statement (annual, 2024-12-31) — Cost Of Revenue: 27729000000.00
PHI balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 59702000000.00
PHI balance_sheet (annual, 2024-12-31) — Current Assets: 63828000000.00
PHI balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 7335000000.00
PHI balance_sheet (annual, 2024-12-31) — Current Debt: 23340000000.00
PHI balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 30675000000.00
PHI balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 10442000000.00
PHI balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 10442000000.00
PHI balance_sheet (annual, 2024-12-31) — Current Liabilities: 188462000000.00
PHI cash_flow (annual, 2024-12-31) — Depreciation: 56228000000.00
PHI cash_flow (quarterly, 2024-12-31) — Depreciation: 18826000000.00
PHI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 56228000000.00
PHI income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 56228000000.00
PHI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 56228000000.00
PHI income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 56228000000.00
PHI income_statement (annual, 2024-12-31) — Depreciation Income Statement: 48539000000.00
PHI income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 18826000000.00
PHI balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
PHI balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
PHI income_statement (annual, 2024-12-31) — Diluted Average Shares: 216447809.00
PHI income_statement (annual, 2024-12-31) — Diluted EPS: 149.26
PHI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 30636000000.00
PHI balance_sheet (annual, 2024-12-31) — Dividends Payable: 2005000000.00
PHI balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 146000000.00
PHI income_statement (annual, 2024-12-31) — EBIT: 55965000000.00
PHI income_statement (annual, 2024-12-31) — EBITDA: 112193000000.00
PHI income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -990000000.00
PHI cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 990000000.00
PHI cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 138000000.00
PHI balance_sheet (annual, 2024-12-31) — Employee Benefits: 3548000000.00
PHI cash_flow (annual, 2024-12-31) — End Cash Position: 10011000000.00
PHI balance_sheet (annual, 2024-12-31) — Financial Assets: 385000000.00
PHI balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1101000000.00
PHI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -22331000000.00
PHI balance_sheet (annual, 2024-12-31) — Finished Goods: 1967000000.00
PHI balance_sheet (quarterly, 2024-12-31) — Finished Goods: 1967000000.00
PHI cash_flow (annual, 2024-12-31) — Free Cash Flow: 13445000000.00
PHI cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -1641000000.00
PHI cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
PHI cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -1527000000.00
PHI income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
PHI income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 1527000000.00
PHI income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 283000000.00
PHI income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 1628000000.00
PHI income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 532000000.00
PHI balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -39233000000.00
PHI income_statement (annual, 2024-12-31) — General And Administrative Expense: 36832000000.00
PHI income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 9208000000.00
PHI balance_sheet (annual, 2024-12-31) — Goodwill: 62941000000.00
PHI balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 64464000000.00
PHI balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 48808000000.00
PHI balance_sheet (annual, 2024-12-31) — Gross PPE: 934036000000.00
PHI income_statement (annual, 2024-12-31) — Gross Profit: 189104000000.00
PHI balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 30000000.00
PHI income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 67000000.00
PHI income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
PHI balance_sheet (annual, 2024-12-31) — Income Tax Payable: 1860000000.00
PHI income_statement (annual, 2024-12-31) — Insurance And Claims: 1408000000.00
PHI income_statement (quarterly, 2024-12-31) — Insurance And Claims: 394000000.00
PHI income_statement (annual, 2024-12-31) — Interest Expense: 15421000000.00
PHI income_statement (quarterly, 2024-12-31) — Interest Expense: 4502000000.00
PHI income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 15421000000.00
PHI income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 4502000000.00
PHI income_statement (annual, 2024-12-31) — Interest Income: 916000000.00
PHI income_statement (quarterly, 2024-12-31) — Interest Income: 198000000.00
PHI income_statement (annual, 2024-12-31) — Interest Income Non Operating: 916000000.00
PHI income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 198000000.00
PHI cash_flow (annual, 2024-12-31) — Interest Paid Cff: -10740000000.00
PHI balance_sheet (annual, 2024-12-31) — Interest Payable: 2426000000.00
PHI cash_flow (annual, 2024-12-31) — Interest Received Cfi: 881000000.00
PHI balance_sheet (annual, 2024-12-31) — Inventory: 3306000000.00
PHI balance_sheet (annual, 2024-12-31) — Invested Capital: 396495000000.00
PHI cash_flow (annual, 2024-12-31) — Investing Cash Flow: -65704000000.00
PHI balance_sheet (annual, 2024-12-31) — Investment Properties: 3000000000.00
PHI balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 4597000000.00
PHI balance_sheet (annual, 2024-12-31) — Investments And Advances: 57361000000.00
PHI balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 18981000000.00
PHI balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 33783000000.00
PHI cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 71000000.00
PHI cash_flow (annual, 2024-12-31) — Issuance Of Debt: 37000000000.00
PHI balance_sheet (annual, 2024-12-31) — Land And Improvements: 49068000000.00
PHI balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 46703000000.00
PHI balance_sheet (annual, 2024-12-31) — Long Term Debt: 258246000000.00
PHI balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 304949000000.00
PHI cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 37000000000.00
PHI cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -28338000000.00
PHI balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 52764000000.00
PHI balance_sheet (annual, 2024-12-31) — Long Term Provisions: 1752000000.00
PHI balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 772075000000.00
PHI balance_sheet (annual, 2024-12-31) — Minority Interest: 1316000000.00
PHI income_statement (annual, 2024-12-31) — Minority Interests: -248000000.00
PHI cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -3770000000.00
PHI balance_sheet (annual, 2024-12-31) — Net Debt: 271575000000.00
PHI cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 36000000.00
PHI income_statement (annual, 2024-12-31) — Net Income: 30695000000.00
PHI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 30636000000.00
PHI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 30943000000.00
PHI income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
PHI income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
PHI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 30695000000.00
PHI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 30695000000.00
PHI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 40544000000.00
PHI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 30943000000.00
PHI cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -29000000.00
PHI income_statement (annual, 2024-12-31) — Net Interest Income: -14584000000.00
PHI income_statement (quarterly, 2024-12-31) — Net Interest Income: -4330000000.00
PHI cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 644000000.00
PHI cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 8662000000.00
PHI cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 8662000000.00
PHI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -14584000000.00
PHI income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -4330000000.00
PHI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 426000000.00
PHI balance_sheet (annual, 2024-12-31) — Net PPE: 357180000000.00
PHI cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -60841000000.00
PHI cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 71000000.00
PHI cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
PHI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 50955000000.00
PHI balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 485000000.00
PHI balance_sheet (annual, 2024-12-31) — Non Current Accrued Expenses: 44000000.00
PHI balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 14643000000.00
PHI balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 7731000000.00
PHI balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 7671000000.00
PHI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 14643000000.00
PHI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 60000000.00
PHI balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3548000000.00
PHI income_statement (annual, 2024-12-31) — Normalized EBITDA: 113359000000.00
PHI income_statement (annual, 2024-12-31) — Normalized Income: 31584886000.39
PHI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 81731000000.00
PHI cash_flow (annual, 2024-12-31) — Operating Gains Losses: 435000000.00
PHI income_statement (annual, 2024-12-31) — Operating Income: 54808000000.00
PHI income_statement (annual, 2024-12-31) — Operating Revenue: 216833000000.00
PHI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (annual, 2024-12-31) — Other Current Assets: 9975000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 23340000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 3903000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -39233000000.00
PHI income_statement (annual, 2024-12-31) — Other Gand A: 9547000000.00
PHI income_statement (quarterly, 2024-12-31) — Other Gand A: 2711000000.00
PHI income_statement (annual, 2024-12-31) — Other Income Expense: 320000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1523000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Inventories: 261000000.00
PHI balance_sheet (quarterly, 2024-12-31) — Other Inventories: 261000000.00
PHI cash_flow (annual, 2024-12-31) — Other Non Cash Items: 13570000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 61929000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 54000000.00
PHI income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 2476000000.00
PHI income_statement (annual, 2024-12-31) — Other Operating Expenses: 30653000000.00
PHI income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 7904000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Properties: 15490000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Receivables: 1401000000.00
PHI balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 992000000.00
PHI income_statement (annual, 2024-12-31) — Other Taxes: 5156000000.00
PHI income_statement (quarterly, 2024-12-31) — Other Taxes: 1176000000.00
PHI balance_sheet (annual, 2024-12-31) — Payables: 74494000000.00
PHI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 134196000000.00
PHI cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 2577000000.00
PHI balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 9246000000.00
PHI balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 450000000.00
PHI balance_sheet (annual, 2024-12-31) — Preferred Stock: 510000000.00
PHI income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 59000000.00
PHI income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 15000000.00
PHI balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 510000000.00
PHI cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 71000000.00
PHI income_statement (annual, 2024-12-31) — Pretax Income: 40544000000.00
PHI balance_sheet (annual, 2024-12-31) — Properties: 0.00
PHI cash_flow (annual, 2024-12-31) — Purchase Of Business: -3770000000.00
PHI cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -29000000.00
PHI cash_flow (annual, 2024-12-31) — Purchase Of Investment: -203000000.00
PHI cash_flow (annual, 2024-12-31) — Purchase Of PPE: -65668000000.00
PHI balance_sheet (annual, 2024-12-31) — Raw Materials: 1078000000.00
PHI balance_sheet (quarterly, 2024-12-31) — Raw Materials: 1078000000.00
PHI balance_sheet (annual, 2024-12-31) — Receivables: 33013000000.00
PHI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 27729000000.00
PHI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 56228000000.00
PHI income_statement (annual, 2024-12-31) — Rent And Landing Fees: 1398000000.00
PHI income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 493000000.00
PHI income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 1398000000.00
PHI income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 493000000.00
PHI cash_flow (annual, 2024-12-31) — Repayment Of Debt: -28338000000.00
PHI balance_sheet (annual, 2024-12-31) — Retained Earnings: 29242000000.00
PHI income_statement (annual, 2024-12-31) — Salaries And Wages: 24479000000.00
PHI income_statement (quarterly, 2024-12-31) — Salaries And Wages: 5610000000.00
PHI cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
PHI cash_flow (annual, 2024-12-31) — Sale Of Investment: 847000000.00
PHI cash_flow (annual, 2024-12-31) — Sale Of PPE: 4827000000.00
PHI income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 5427000000.00
PHI income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 1216000000.00
PHI income_statement (annual, 2024-12-31) — Selling General And Administration: 42259000000.00
PHI balance_sheet (annual, 2024-12-31) — Share Issued: 219055775.00
PHI cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
PHI cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
PHI income_statement (annual, 2024-12-31) — Special Income Charges: -2794000000.00
PHI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 115419000000.00
PHI balance_sheet (annual, 2024-12-31) — Tangible Book Value: 50445000000.00
PHI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -276113999.61
PHI income_statement (annual, 2024-12-31) — Tax Provision: 9601000000.00
PHI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.24
PHI cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -3282000000.00
PHI balance_sheet (annual, 2024-12-31) — Total Assets: 623275000000.00
PHI balance_sheet (annual, 2024-12-31) — Total Capitalization: 373665000000.00
PHI balance_sheet (annual, 2024-12-31) — Total Debt: 335624000000.00
PHI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 116735000000.00
PHI income_statement (annual, 2024-12-31) — Total Expenses: 162025000000.00
PHI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 506540000000.00
PHI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 559447000000.00
PHI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 318078000000.00
PHI income_statement (annual, 2024-12-31) — Total Other Finance Cost: 79000000.00
PHI income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 26000000.00
PHI balance_sheet (annual, 2024-12-31) — Total Tax Payable: 11240000000.00
PHI income_statement (annual, 2024-12-31) — Total Unusual Items: -1166000000.00
PHI income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1166000000.00
PHI balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 3000000.00
PHI balance_sheet (annual, 2024-12-31) — Treasury Stock: 6505000000.00
PHI balance_sheet (annual, 2024-12-31) — Working Capital: -124634000000.00
PHI income_statement (annual, 2024-12-31) — Write Off: 4254000000.00
PHI income_statement (quarterly, 2025-03-31) — +Operating Expense: 31852000000.00
PHI income_statement (quarterly, 2025-03-31) — +Total Revenue: 55277000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 54162000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 31362000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -588896000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 130312000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -18051000000.00